Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02869243
Brief Title: A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients

First Submitted : August 2, 2016
First Submitted that Met QC Criteria : August 11, 2016
First Posted : August 16, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 17, 2020
Last Update Posted : November 19, 2020